GLP-1 and pegGLP-1 treatment caused a significant increase in the number of CD31+ cells in mice lungs under MSG and CSE administration compared to untreated mice with MD and emphysema of the lungs (Figure 5). This evidence concerns the gene GLP1R and Menkes disease.